血管内照射防治血管成形术后再狭窄

王卫东

血管内照射防治血管成形术后再狭窄

王卫东

文章导航 > 国际放射医学核医学杂志 > 2002, 26 > 4: (152-155)

引用本文:

Citation:

血管内照射防治血管成形术后再狭窄

王卫东

200032 上海, 复旦大学附属中山医院核医学科

作者简介: 王卫东(1968-),男,上海崇明人,博士研究生,主要从事核素治疗学研究。;

中图分类号: R817.5

Endovascular irradiation for the prevention of restenosis after angio plasty

WANG Wei-dong

Zhongshan Hospital Medical Center of Fudan University, Shanghai 200032, China
CLC number: R817.5

摘要: PTCA(经皮穿刺冠状动脉成形术)是治疗冠状动脉狭窄最常用的方法,但术后6个月内再狭窄的发生率达40%~60%,始终是困绕医学界的一个难题。核素内照射治疗是目前解决这一难题最有前景的方法,最近几年来在血管核素内照射的机制、剂量、动物和临床实验及安全性等方面取得了一些进展。
- 经皮穿刺冠状动脉成形术 /
- 再狭窄 /
- 血管内照射治疗
Abstract: Percutaneous transluminal coronary angioplasty (PTCA)is the most common technique for the restenosis of coronary arteries.Restenosis,Which is an unsolved clinical problem occurs within 6 months in 40%~60% of all cases.At present,endovascular irradiation with radioistope is a promising method to overcome restenosis.This article mainly disscusses the mechanism,doses,animal and clinical experiments and safety of intravascular brachytherapy.It is a review of relatively recently developed field of this technique.
- percutaneous transluminal coronary angioplasty /
- restenosis /
- intravascular brachytherapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Mintz GS, Pichard AD, Kent K, et al. Endovascular stents reduce restenosis by eliminating geometric arterial remodeling:a serial intravascrlandtrasound intravascular-uhrasound study[J]. J Am Coll Cardiol, 1995, 35A:701-705.
[2]	Teristein PS. Gamma versus beta radiation for the treament of restenosis[J]. Herz, 1998, 23:335-336.
[3]	Amols HI, Trichter F, Weinberger J. Intracoronary radiation for prevention of restenosis:dose perturbation caused by stents[J].Circulation, 1998, 98:2024-2029.
[4]	Kotzerke J, Rentschler M, Glatting G, et al. Dosimetry fundamentals of endovsacular therapy using Re-188 for the prevention of restenosis after angioplasty[J]. Nuklerarmedizin, 1998, 37(2):68-72.
[5]	Nath RC. Intravascular brachytherapy physics:report of AAPM Radiation Therapy Committee Task Group No.60[J]. Med Phys, 1999, 26:119-152.
[6]	Cousey BM, Colle R, Zimmerman BE. National radioactivity standards for beta-emitting radionnuclides used in intravascular brachytherapy[J]. Int J Radiat Oncol Bid Phys, 1998, 41:207-216.
[7]	Wohlfrom M, Kotzerke J, Kamenz J, et al. Endovascular irradiation with the liquid beta-emitter Rhenium-188 to reduce restenosis after experimental wall injury[J].Cardivasc Res, 2001, 49(1):169-176.
[8]	Lee J, Lee DS, Kim KM, et al. Dosimetry of rheniun-188 diethylene triamine penta-acetic acid for endvascular intraballoon brachytherapy after coronary angioplasty[J]. Eur J Nucl Med, 2000, 27(1):76-82.
[9]	Janicki C, Duggan DM, Coffey CW. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent[J]. Med Phys, 1997, 24:437-445.
[10]	Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endovascular stentts prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits[J]. Circulation, 1995, 92(6):1570-1575.
[11]	Weiberger J. Use of liquid-filled balloons for coronary irradiation[A] In:Waksman R,ed. Vascular brachytherapy[M], 2nd edn. Armon, New York:futura, 1999. 521-536.
[12]	Makkar R, Whiting J, Li A, et al. Abeta-emitting liquid isotope filled balloon markedly inhibits restenosis in stented porcine coronary arteries[J]. J Am Coll Cardiol, 1998, 31(Suppl A):350A.
[13]	Condado JA, Waksman R, Calderas C, et al. Two-year follow-up after intracoronary gamma radiation therapy[J]. Cardiovasc Radiat Med, 1999, 1(1):30-35.
[14]	Coen VL, Knook AH, Wardeh AJ, et al. Endovascular brachytherapy in coronary arteries:the rotterdam experience[J]. Cardiovasc Radiat Med, 2000, 2(1):42-50.
[15]	Fox RA, Barker P, Guy D, et al. The use of ¹⁸⁸Re to treat instent re-stenosis of coronary arteries[J]. Australas Phys Eng Sci Med, 2001, 24(3):160-165.
[16]	Amols HI. Methods to improve dose uniformity for radioactive stents in endovascular brachytherapy[J]. Cardiovasc Radiat Med, 1999, 1(3):270-277.
[17]	Giap H, Massullo V, Teirstein P, et al. Theoretical assessment of late cardiac complication from endovascular brachytherapy for restenosis prevention[J]. Cardiovasc Radiat Med, 1999, 1(3):233-238.
[18]	Teirstein PS, Massullo V, Jani S, et al. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis[J]. Circulation, 1999, 99(2):243-247.
[19]	Xu Z, Yang G, Reinstein LE, et al. Caculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy[J]. Cardiovasc Radiat Med, 2000, 2(1):26-31.

[1]	庄永志 , 王俊杰 . 放疗抑制血管成形术后再狭窄的研究进展. 国际放射医学核医学杂志, 2001, 25(5): 228-232.
[2]	刘宏莉 . 核素内照射防治血管成形术后再狭窄. 国际放射医学核医学杂志, 2001, 25(1): 38-41.
[3]	庄永志 , 王俊杰 . 射线对血管平滑肌细胞抑制作用的机制. 国际放射医学核医学杂志, 2001, 25(1): 27-30.
[4]	谭文庆 . 冠状动脉内放射治疗再狭窄的研究近况. 国际放射医学核医学杂志, 2003, 27(4): 145-147.
[5]	王任飞 , 谭建 . 血管腔内近距离照射预防介入治疗后再狭窄的研究现状. 国际放射医学核医学杂志, 2001, 25(4): 153-157.
[6]	陈建伟 . 电离辐射对血管内皮细胞影响的研究. 国际放射医学核医学杂志, 2001, 25(1): 33-37.
[7]	张金山 , 蒋宁一 . 放射性血管内支架——防治冠状动脉再狭窄. 国际放射医学核医学杂志, 1999, 23(4): 162-164.
[8]	任晓庆 . β源放射性支架的“糖果纸”样现象. 国际放射医学核医学杂志, 2001, 25(1): 31-33.
[9]	杨波 , 刘长春 , 张勇 , 卢汝虹 . ⁹⁹Tc^m-MIBI运动负荷-静息心肌灌注显像对冠心病患者经皮腔内冠状动脉血管成形术的疗效评价. 国际放射医学核医学杂志, 2009, 33(1): 37-39. doi: 10.3760/cma.j.issn.1673-4114.2009.01.037
[10]	王俊杰 , 申文江 , 贾廷珍 . 放射性支架对血管成形术后再狭窄的预防作用. 国际放射医学核医学杂志, 1999, 23(6): 260-262.